bonyf NV / Key word(s): Annual Results bonyf NV: bonyf’s 2023 financial statements made available 28-Jun-2024 / 17:12 CET/CEST
Dissemination of a Financial Wire News, transmitted by EQS Group. |
BMS details confirmatory trial win for KRAS inhibitor Krazati
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS